TGA Approval

MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube (212325)

ARTG ID

212325

ARTG Name

MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube

Sponsor

Galderma Australia Pty Ltd

ARTG Date

August 4, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GALDERMA AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/19dcd32d5a2b1d256defdeac7aa086e7.pdf

https://medical-cdn.nocode.com/drug_tga/6e05c19251b3ba1b7473040280ae4acc.pdf

Ingredient Name

brimonidine tartrate

Empowering clinical research with data-driven insights and AI-powered tools.

MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube (212325) - TGA 批准文号 | MedPath